AR133375A1 - Compuestos novedosos - Google Patents
Compuestos novedososInfo
- Publication number
- AR133375A1 AR133375A1 ARP240101971A ARP240101971A AR133375A1 AR 133375 A1 AR133375 A1 AR 133375A1 AR P240101971 A ARP240101971 A AR P240101971A AR P240101971 A ARP240101971 A AR P240101971A AR 133375 A1 AR133375 A1 AR 133375A1
- Authority
- AR
- Argentina
- Prior art keywords
- novel compounds
- compounds
- novel
- methods
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a compuestos novedosos que tienen la fórmula general (1) en donde X, R¹, R², R³ y n son como se describen en la presente, composición que incluye los compuestos y métodos para usar los compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23188312 | 2023-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR133375A1 true AR133375A1 (es) | 2025-09-24 |
Family
ID=87520076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP240101971A AR133375A1 (es) | 2023-07-28 | 2024-07-26 | Compuestos novedosos |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20260193239A1 (es) |
| EP (1) | EP4754096A1 (es) |
| CN (1) | CN121586712A (es) |
| AR (1) | AR133375A1 (es) |
| TW (1) | TW202510869A (es) |
| WO (1) | WO2025026882A1 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT4337652T (lt) | 2021-05-12 | 2025-06-25 | F. Hoffmann-La Roche Ag | Nlrp3 inhibitoriai |
| EP4347571B1 (en) * | 2021-06-04 | 2026-04-22 | F. Hoffmann-La Roche AG | Triazine derivatives and their use in the treatment of cancer. |
| WO2024099993A1 (en) * | 2022-11-09 | 2024-05-16 | F. Hoffmann-La Roche Ag | Triazinone derivatives as nlrp3 inhibitors |
-
2024
- 2024-07-25 CN CN202480049343.9A patent/CN121586712A/zh active Pending
- 2024-07-25 EP EP24745460.6A patent/EP4754096A1/en active Pending
- 2024-07-25 WO PCT/EP2024/071174 patent/WO2025026882A1/en not_active Ceased
- 2024-07-26 TW TW113127708A patent/TW202510869A/zh unknown
- 2024-07-26 AR ARP240101971A patent/AR133375A1/es unknown
-
2026
- 2026-01-22 US US19/456,280 patent/US20260193239A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025026882A1 (en) | 2025-02-06 |
| CN121586712A (zh) | 2026-02-27 |
| EP4754096A1 (en) | 2026-06-10 |
| US20260193239A1 (en) | 2026-07-09 |
| TW202510869A (zh) | 2025-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR131006A1 (es) | Compuestos novedosos | |
| AR131282A1 (es) | Compuestos novedosos | |
| AR130984A1 (es) | Compuestos novedosos | |
| AR123424A1 (es) | Nuevos compuestos heterocíclicos | |
| CL2021001330A1 (es) | Nuevos compuestos heterocíclicos | |
| CL2023003154A1 (es) | Compuestos heterocíclicos | |
| CO2023016204A2 (es) | Inhibidores de nlrp3 | |
| AR132377A1 (es) | Compuestos novedosos | |
| CL2024004085A1 (es) | Compuestos macrocíclicos inhibidores de kras, uso para tratar cáncer. | |
| CL2022001091A1 (es) | Dihidrobenzofurano e inden analogos como inhibidores de sarcómero cardíaco (divisional de solicitud 202001871). | |
| CO2022002000A2 (es) | Nuevos inhibidores heterocíclicos de monoacilglicerol lipasa (magl) | |
| CL2023002429A1 (es) | Derivados novedosos de pirimidin-2-il sulfonamida | |
| AR131278A1 (es) | Compuestos novedosos | |
| CL2022000019A1 (es) | Nuevos compuestos heterocíclicos | |
| CO2022002336A2 (es) | Compuestos heterocíclicos | |
| CO2022003062A2 (es) | Compuestos heterocíclicos | |
| AR132456A1 (es) | Compuestos novedosos | |
| CR20240203A (es) | Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2 | |
| CO2025003256A2 (es) | Derivados novedosos deuterados de pirimidin-2-il sulfonamida | |
| CL2025000126A1 (es) | Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina. | |
| CL2025000125A1 (es) | Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina. | |
| AR133076A1 (es) | Compuestos novedosos | |
| MX2022005912A (es) | Compuestos de 1,8-naftiridin-2-ona para el tratamiento de una enfermedad autoinmunitaria. | |
| AR131633A1 (es) | Derivados novedosos de pirimidinil sulfonamida | |
| MX2024000022A (es) | Compuestos terapeuticos. |